While this observational study could not determine causal relationships among these three features of CF intestinal dysfunction, these findings identify bacterial taxa and activities that could contribute to CF GI symptoms, which have not responded as robustly to CFTR modulators as initially hoped [22]. The gene discussed is CFTR; the disease is cystic fibrosis.